Literature DB >> 9495674

Immunological differentiation between tickborne encephalitis with and without concomitant neuroborreliosis.

J Tomazic1, A Ihan, F Strle, J Cimperman, J Stare, M Maticic, B Zakotnik.   

Abstract

Cerebrospinal fluid lymphocyte subsets in patients with tickborne encephalitis (TBE) and in patients with TBE with concomitant neuroborreliosis (double infection) were analysed by flow cytometry. In the TBE group, higher percentages of CD4+DR+ T cells (p = 0.02) and CD25+ T cells (p = 0.0002) were observed, while in the group with double infection, higher percentages of CD19+ cells (p = 0.007), CD8+DR- T cells (p = 0.04), and CD3+CD71 + T cells (p = 0.0002) were found. It was concluded that several differences in immune cell parameters are present between the two groups of patients. Three variables (CD19+ cells, CD3+CD25+ T cells, CD3+CD71+ T cells) were included in the logistic regression model for calculation of probability for double infection. Flow cytometric characterisation of lymphocyte subsets in CSF can further substantiate the diagnosis of concomitant neuroborreliosis in patients with TBE.

Entities:  

Mesh:

Year:  1997        PMID: 9495674     DOI: 10.1007/BF01700560

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  16 in total

1.  The proliferation rate of T and B lymphocytes in cerebrospinal fluid.

Authors:  R S Thomas; W Beuche; K Felgenhauer
Journal:  J Neurol       Date:  1991-02       Impact factor: 4.849

2.  Tick-borne viral encephalitis in Finland. The clinical features of Kumlinge disease during 1959-1987.

Authors:  P Wahlberg; P Saikku; M Brummer-Korvenkontio
Journal:  J Intern Med       Date:  1989-03       Impact factor: 8.989

3.  Diagnostic significance of IgG-synthesizing activated B cells in acute inflammatory diseases of the central nervous system.

Authors:  H J Schädlich; K Felgenhauer
Journal:  Klin Wochenschr       Date:  1985-06-03

4.  Antigens of Lyme disease of spirochaete Borrelia burgdorferi inhibits antigen or mitogen-induced lymphocyte proliferation.

Authors:  J W Chiao; C Pavia; M Riley; W Altmann-Lasekan; M Abolhassani; K Liegner; A Mittelman
Journal:  FEMS Immunol Med Microbiol       Date:  1994-02

5.  Cellular immunoregulatory mechanisms in the central nervous system: characterization of noninflammatory and inflammatory cerebrospinal fluid lymphocytes.

Authors:  M Matsui; K J Mori; T Saida
Journal:  Ann Neurol       Date:  1990-06       Impact factor: 10.422

6.  Comparison of two methods for detecting intrathecal synthesis of Borrelia burgdorferi-specific antibodies and PCR for diagnosis of Lyme neuroborreliosis.

Authors:  R Zbinden; D Goldenberger; G M Lucchini; M Altwegg
Journal:  J Clin Microbiol       Date:  1994-07       Impact factor: 5.948

7.  Specific antigen binding by activated cerebrospinal fluid B lymphocytes in acute neuroborreliosis.

Authors:  W Beuche; A Siever; K Felgenhauer
Journal:  J Neurol       Date:  1992-07       Impact factor: 4.849

8.  The triad of neurologic manifestations of Lyme disease: meningitis, cranial neuritis, and radiculoneuritis.

Authors:  A R Pachner; A C Steere
Journal:  Neurology       Date:  1985-01       Impact factor: 9.910

9.  Invasion of the central nervous system by Borrelia burgdorferi in acute disseminated infection.

Authors:  B J Luft; C R Steinman; H C Neimark; B Muralidhar; T Rush; M F Finkel; M Kunkel; R J Dattwyler
Journal:  JAMA       Date:  1992-03-11       Impact factor: 56.272

10.  Natural killer cells and lymphocyte subsets in active MS and acute inflammation of the CNS.

Authors:  E Merelli; P Sola; P Faglioni; S Giordani; D Mussini; G Montagnani
Journal:  Acta Neurol Scand       Date:  1991-08       Impact factor: 3.209

View more
  1 in total

Review 1.  Human Co-Infections between Borrelia burgdorferi s.l. and Other Ixodes-Borne Microorganisms: A Systematic Review.

Authors:  Pierre H Boyer; Cédric Lenormand; Benoît Jaulhac; Emilie Talagrand-Reboul
Journal:  Pathogens       Date:  2022-02-23
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.